Table 3

Multivariate analysis of prognostic factors for progression of SMM to myeloma and related disorders

Prognostic factorHazard ratio (95% CI)P
Bone marrow plasma cells more than 10% 3.1 (1.6-6.3) < .01 
Abnormal FLC ratio less than 0.125 or more than 8 1.9 (1.3-2.7) < .01 
Serum M protein size, more than 30 g/L 1.9 (1.4-2.6) < .01 
Prognostic factorHazard ratio (95% CI)P
Bone marrow plasma cells more than 10% 3.1 (1.6-6.3) < .01 
Abnormal FLC ratio less than 0.125 or more than 8 1.9 (1.3-2.7) < .01 
Serum M protein size, more than 30 g/L 1.9 (1.4-2.6) < .01 
Close Modal

or Create an Account

Close Modal
Close Modal